Detalhe da pesquisa
1.
Perampanel for the treatment of people with idiopathic generalized epilepsy in clinical practice.
Epilepsia
; 64(8): 2094-2107, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37114853
2.
Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.
Acta Neurol Scand
; 142(6): 563-573, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32691850
3.
Eslicarbazepine acetate as monotherapy in clinical practice: Outcomes from Euro-Esli.
Acta Neurol Scand
; 139(1): 49-63, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30176048
4.
Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
Epilepsy Behav
; 76: 63-70, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28927712
5.
Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study.
Epilepsy Res
; 202: 107339, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492461
6.
Perampanel outcomes at different stages of treatment in people with focal and generalized epilepsy treated in clinical practice: Evidence from the PERMIT study.
Front Neurol
; 14: 1120150, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37064177
7.
Perampanel for the treatment of patients with myoclonic seizures in clinical practice: Evidence from the PERMIT study.
Seizure
; 100: 56-66, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777333
8.
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.
J Neurol
; 269(4): 1957-1977, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34427754
9.
Predictors of seizure freedom, response and retention after 12 months of treatment with eslicarbazepine acetate: A post-hoc analysis of the Euro-Esli study.
Epilepsy Res
; 174: 106653, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049227
10.
Safety, tolerability and effectiveness of transition to eslicarbazepine acetate from carbamazepine or oxcarbazepine in clinical practice.
Seizure
; 75: 121-128, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31981862
11.
Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study.
Neurol Ther
; 8(2): 491-504, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31098888
12.
Novel seizure outcomes in patients with Lennox-Gastaut syndrome: Post hoc analysis of seizure-free days in rufinamide Study 303.
Epilepsia Open
; 4(2): 275-280, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168494
13.
Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study.
J Neurol Sci
; 402: 88-99, 2019 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128460
14.
Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
Epileptic Disord
; 20(1): 13-29, 2018 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29313492
15.
Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
Neurol Ther
; 7(2): 195-206, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30251237
16.
Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures.
J Neurol
; 264(11): 2232-2248, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28921040
17.
Treatment of Adults with Lennox-Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide.
Neurol Ther
; 5(1): 35-43, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26861566
18.
Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM.
Seizure
; 34: 66-73, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26735004